-
1
-
-
3242805932
-
The role of cell adhesion molecule in cancer progression and its application in cancer therapy
-
Okegawa T, Pong RC, Li Y, Hsieh JT, (2004) The role of cell adhesion molecule in cancer progression and its application in cancer therapy. Acta Biochim Pol 51: 445-457.
-
(2004)
Acta Biochim Pol
, vol.51
, pp. 445-457
-
-
Okegawa, T.1
Pong, R.C.2
Li, Y.3
Hsieh, J.T.4
-
2
-
-
33947536338
-
Simple histone acetylation plays a complex role in the regulation of gene expression
-
Fukuda H, Sano N, Muto S, Horikoshi M, (2006) Simple histone acetylation plays a complex role in the regulation of gene expression. Brief Funct Genomic Proteomic 5: 190-208.
-
(2006)
Brief Funct Genomic Proteomic
, vol.5
, pp. 190-208
-
-
Fukuda, H.1
Sano, N.2
Muto, S.3
Horikoshi, M.4
-
3
-
-
57749170458
-
The many roles of histone deacetylases in development and physiology: Implications for disease and therapy
-
Haberland M, Montgomery RL, Olson EN, (2009) The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nat Rev Genet 10: 32-42.
-
(2009)
Nat Rev Genet
, vol.10
, pp. 32-42
-
-
Haberland, M.1
Montgomery, R.L.2
Olson, E.N.3
-
5
-
-
9444238027
-
The histone deacetylase inhibitor FR901228 induces caspase-dependent apoptosis via the mitochondrial pathway in small cell lung cancer cells
-
Doi S, Soda H, Oka M, Tsurutani J, Kitazaki T, et al. (2004) The histone deacetylase inhibitor FR901228 induces caspase-dependent apoptosis via the mitochondrial pathway in small cell lung cancer cells. Mol Cancer Ther 3: 1397-1402.
-
(2004)
Mol Cancer Ther
, vol.3
, pp. 1397-1402
-
-
Doi, S.1
Soda, H.2
Oka, M.3
Tsurutani, J.4
Kitazaki, T.5
-
6
-
-
11844298984
-
Sensitization of osteosarcoma cells to death receptor-mediated apoptosis by HDAC inhibitors through downregulation of cellular FLIP
-
Watanabe K, Okamoto K, Yonehara S, (2005) Sensitization of osteosarcoma cells to death receptor-mediated apoptosis by HDAC inhibitors through downregulation of cellular FLIP. Cell Death Differ 12: 10-18.
-
(2005)
Cell Death Differ
, vol.12
, pp. 10-18
-
-
Watanabe, K.1
Okamoto, K.2
Yonehara, S.3
-
7
-
-
0242610345
-
The histone deacetylase inhibitor FK228 preferentially enhances adenovirus transgene expression in malignant cells
-
Goldsmith ME, Kitazono M, Fok P, Aikou T, Bates S, et al. (2003) The histone deacetylase inhibitor FK228 preferentially enhances adenovirus transgene expression in malignant cells. Clin Cancer Res 9: 5394-5401.
-
(2003)
Clin Cancer Res
, vol.9
, pp. 5394-5401
-
-
Goldsmith, M.E.1
Kitazono, M.2
Fok, P.3
Aikou, T.4
Bates, S.5
-
8
-
-
19944432566
-
A phase 1 and pharmacodynamic study of depsipeptide (FK228) in chronic lymphocytic leukemia and acute myeloid leukemia
-
Byrd JC, Marcucci G, Parthun MR, Xiao JJ, Klisovic RB, et al. (2005) A phase 1 and pharmacodynamic study of depsipeptide (FK228) in chronic lymphocytic leukemia and acute myeloid leukemia. Blood 105: 959-967.
-
(2005)
Blood
, vol.105
, pp. 959-967
-
-
Byrd, J.C.1
Marcucci, G.2
Parthun, M.R.3
Xiao, J.J.4
Klisovic, R.B.5
-
10
-
-
70549105748
-
Phase II, two-stage, single-arm trial of the histone deacetylase inhibitor (HDACi) romidepsin in metastatic castration-resistant prostate cancer (CRPC)
-
Molife LR, Attard G, Fong PC, Karavasilis V, Reid AH, et al. (2010) Phase II, two-stage, single-arm trial of the histone deacetylase inhibitor (HDACi) romidepsin in metastatic castration-resistant prostate cancer (CRPC). Ann Oncol 21: 109-113.
-
(2010)
Ann Oncol
, vol.21
, pp. 109-113
-
-
Molife, L.R.1
Attard, G.2
Fong, P.C.3
Karavasilis, V.4
Reid, A.H.5
-
11
-
-
34548438593
-
Enhanced therapeutic effect on androgen-independent prostate cancer by depsipeptide (FK228), a histone deacetylase inhibitor, in combination with docetaxel
-
Zhang Z, Stanfield J, Frenkel E, Kabbani W, Hsieh JT, (2007) Enhanced therapeutic effect on androgen-independent prostate cancer by depsipeptide (FK228), a histone deacetylase inhibitor, in combination with docetaxel. Urology 70: 396-401.
-
(2007)
Urology
, vol.70
, pp. 396-401
-
-
Zhang, Z.1
Stanfield, J.2
Frenkel, E.3
Kabbani, W.4
Hsieh, J.T.5
-
12
-
-
34249949312
-
Low concentrations of the histone deacetylase inhibitor, depsipeptide, enhance the effects of gemcitabine and docetaxel in hormone refractory prostate cancer cells
-
Kanzaki M, Kakinuma H, Kumazawa T, Inoue T, Saito M, et al. (2007) Low concentrations of the histone deacetylase inhibitor, depsipeptide, enhance the effects of gemcitabine and docetaxel in hormone refractory prostate cancer cells. Oncol Rep 17: 761-767.
-
(2007)
Oncol Rep
, vol.17
, pp. 761-767
-
-
Kanzaki, M.1
Kakinuma, H.2
Kumazawa, T.3
Inoue, T.4
Saito, M.5
-
13
-
-
42249107488
-
Histone deacetylase inhibitor FK228 enhances adenovirus-mediated p53 family gene therapy in cancer models
-
Sasaki Y, Negishi H, Idogawa M, Suzuki H, Mita H, et al. (2008) Histone deacetylase inhibitor FK228 enhances adenovirus-mediated p53 family gene therapy in cancer models. Mol Cancer Ther 7: 779-787.
-
(2008)
Mol Cancer Ther
, vol.7
, pp. 779-787
-
-
Sasaki, Y.1
Negishi, H.2
Idogawa, M.3
Suzuki, H.4
Mita, H.5
-
14
-
-
33847397884
-
The histone deacetylase inhibitor FK228 given prior to adenovirus infection can boost infection in melanoma xenograft model systems
-
Goldsmith ME, Aguila A, Steadman K, Martinez A, Steinberg SM, et al. (2007) The histone deacetylase inhibitor FK228 given prior to adenovirus infection can boost infection in melanoma xenograft model systems. Mol Cancer Ther 6: 496-505.
-
(2007)
Mol Cancer Ther
, vol.6
, pp. 496-505
-
-
Goldsmith, M.E.1
Aguila, A.2
Steadman, K.3
Martinez, A.4
Steinberg, S.M.5
-
15
-
-
0035418558
-
Enhanced adenovirus transgene expression in malignant cells treated with the histone deacetylase inhibitor FR901228
-
Kitazono M, Goldsmith ME, Aikou T, Bates S, Fojo T, (2001) Enhanced adenovirus transgene expression in malignant cells treated with the histone deacetylase inhibitor FR901228. Cancer Res 61: 6328-6330.
-
(2001)
Cancer Res
, vol.61
, pp. 6328-6330
-
-
Kitazono, M.1
Goldsmith, M.E.2
Aikou, T.3
Bates, S.4
Fojo, T.5
-
16
-
-
33748989559
-
Mechanism of increased coxsackie and adenovirus receptor gene expression and adenovirus uptake by phytoestrogen and histone deacetylase inhibitor in human bladder cancer cells and the potential clinical application
-
Pong RC, Roark R, Ou JY, Fan J, Stanfield J, et al. (2006) Mechanism of increased coxsackie and adenovirus receptor gene expression and adenovirus uptake by phytoestrogen and histone deacetylase inhibitor in human bladder cancer cells and the potential clinical application. Cancer Res 66: 8822-8828.
-
(2006)
Cancer Res
, vol.66
, pp. 8822-8828
-
-
Pong, R.C.1
Roark, R.2
Ou, J.Y.3
Fan, J.4
Stanfield, J.5
-
17
-
-
29144485434
-
Histone deacetylase inhibitor FR901228 enhances the antitumor effect of telomerase-specific replication-selective adenoviral agent OBP-301 in human lung cancer cells
-
Watanabe T, Hioki M, Fujiwara T, Nishizaki M, Kagawa S, et al. (2006) Histone deacetylase inhibitor FR901228 enhances the antitumor effect of telomerase-specific replication-selective adenoviral agent OBP-301 in human lung cancer cells. Exp Cell Res 312: 256-265.
-
(2006)
Exp Cell Res
, vol.312
, pp. 256-265
-
-
Watanabe, T.1
Hioki, M.2
Fujiwara, T.3
Nishizaki, M.4
Kagawa, S.5
-
18
-
-
0347320795
-
Epigenetic regulation of coxsackie and adenovirus receptor (CAR) gene promoter in urogenital cancer cells
-
Pong RC, Lai YJ, Chen H, Okegawa T, Frenkel E, et al. (2003) Epigenetic regulation of coxsackie and adenovirus receptor (CAR) gene promoter in urogenital cancer cells. Cancer Res 63: 8680-8686.
-
(2003)
Cancer Res
, vol.63
, pp. 8680-8686
-
-
Pong, R.C.1
Lai, Y.J.2
Chen, H.3
Okegawa, T.4
Frenkel, E.5
-
19
-
-
0038353969
-
Ex vivo stimulation of cytomegalovirus (CMV)-specific T cells using CMV pp65-modified dendritic cells as stimulators
-
Carlsson B, Cheng WS, Totterman TH, Essand M, (2003) Ex vivo stimulation of cytomegalovirus (CMV)-specific T cells using CMV pp65-modified dendritic cells as stimulators. Br J Haematol 121: 428-438.
-
(2003)
Br J Haematol
, vol.121
, pp. 428-438
-
-
Carlsson, B.1
Cheng, W.S.2
Totterman, T.H.3
Essand, M.4
-
20
-
-
40549092679
-
Increased therapeutic efficacy of the prostate-specific oncolytic adenovirus Ad[I/PPT-E1A] by reduction of the insulator size and introduction of the full-length E3 region
-
Danielsson A, Dzojic H, Nilsson B, Essand M, (2008) Increased therapeutic efficacy of the prostate-specific oncolytic adenovirus Ad[I/PPT-E1A] by reduction of the insulator size and introduction of the full-length E3 region. Cancer Gene Ther 15: 203-213.
-
(2008)
Cancer Gene Ther
, vol.15
, pp. 203-213
-
-
Danielsson, A.1
Dzojic, H.2
Nilsson, B.3
Essand, M.4
-
21
-
-
4344625021
-
A novel TARP-promoter-based adenovirus against hormone-dependent and hormone-refractory prostate cancer
-
Cheng WS, Kraaij R, Nilsson B, van der Weel L, de Ridder CM, et al. (2004) A novel TARP-promoter-based adenovirus against hormone-dependent and hormone-refractory prostate cancer. Mol Ther 10: 355-364.
-
(2004)
Mol Ther
, vol.10
, pp. 355-364
-
-
Cheng, W.S.1
Kraaij, R.2
Nilsson, B.3
van der Weel, L.4
de Ridder, C.M.5
-
22
-
-
2442667692
-
Adenovirus CD40 ligand gene therapy counteracts immune escape mechanisms in the tumor Microenvironment
-
Loskog A, Dzojic H, Vikman S, Ninalga C, Essand M, et al. (2004) Adenovirus CD40 ligand gene therapy counteracts immune escape mechanisms in the tumor Microenvironment. J Immunol 172: 7200-7205.
-
(2004)
J Immunol
, vol.172
, pp. 7200-7205
-
-
Loskog, A.1
Dzojic, H.2
Vikman, S.3
Ninalga, C.4
Essand, M.5
-
23
-
-
34247855984
-
A novel chromogranin-A promoter-driven oncolytic adenovirus for midgut carcinoid therapy
-
Leja J, Dzojic H, Gustafson E, Oberg K, Giandomenico V, et al. (2007) A novel chromogranin-A promoter-driven oncolytic adenovirus for midgut carcinoid therapy. Clin Cancer Res 13: 2455-2462.
-
(2007)
Clin Cancer Res
, vol.13
, pp. 2455-2462
-
-
Leja, J.1
Dzojic, H.2
Gustafson, E.3
Oberg, K.4
Giandomenico, V.5
-
24
-
-
1642578443
-
Development of an adenoviral vector system with adenovirus serotype 35 tropism; efficient transient gene transfer into primary malignant hematopoietic cells
-
Nilsson M, Ljungberg J, Richter J, Kiefer T, Magnusson M, et al. (2004) Development of an adenoviral vector system with adenovirus serotype 35 tropism; efficient transient gene transfer into primary malignant hematopoietic cells. J Gene Med 6: 631-641.
-
(2004)
J Gene Med
, vol.6
, pp. 631-641
-
-
Nilsson, M.1
Ljungberg, J.2
Richter, J.3
Kiefer, T.4
Magnusson, M.5
-
25
-
-
1642443428
-
Functionally distinct subpopulations of cord blood CD34+ cells are transduced by adenoviral vectors with serotype 5 or 35 tropism
-
Nilsson M, Karlsson S, Fan X, (2004) Functionally distinct subpopulations of cord blood CD34+ cells are transduced by adenoviral vectors with serotype 5 or 35 tropism. Mol Ther 9: 377-388.
-
(2004)
Mol Ther
, vol.9
, pp. 377-388
-
-
Nilsson, M.1
Karlsson, S.2
Fan, X.3
-
26
-
-
34249074258
-
Valproic acid induces neuroendocrine differentiation and UGT2B7 up-regulation in human prostate carcinoma cell line
-
Valentini A, Biancolella M, Amati F, Gravina P, Miano R, et al. (2007) Valproic acid induces neuroendocrine differentiation and UGT2B7 up-regulation in human prostate carcinoma cell line. Drug Metab Dispos 35: 968-972.
-
(2007)
Drug Metab Dispos
, vol.35
, pp. 968-972
-
-
Valentini, A.1
Biancolella, M.2
Amati, F.3
Gravina, P.4
Miano, R.5
-
27
-
-
41649097549
-
Differential effects of prostate cancer therapeutics on neuroendocrine transdifferentiation
-
Frigo DE, McDonnell DP, (2008) Differential effects of prostate cancer therapeutics on neuroendocrine transdifferentiation. Mol Cancer Ther 7: 659-669.
-
(2008)
Mol Cancer Ther
, vol.7
, pp. 659-669
-
-
Frigo, D.E.1
McDonnell, D.P.2
-
28
-
-
13644251766
-
Impact of novel histone deacetylase inhibitors, CHAP31 and FR901228 (FK228), on adenovirus-mediated transgene expression
-
Taura K, Yamamoto Y, Nakajima A, Hata K, Uchinami H, et al. (2004) Impact of novel histone deacetylase inhibitors, CHAP31 and FR901228 (FK228), on adenovirus-mediated transgene expression. J Gene Med 6: 526-536.
-
(2004)
J Gene Med
, vol.6
, pp. 526-536
-
-
Taura, K.1
Yamamoto, Y.2
Nakajima, A.3
Hata, K.4
Uchinami, H.5
-
29
-
-
0019805264
-
Adenovirus chromatin structure at different stages of infection
-
Daniell E, Groff DE, Fedor MJ, (1981) Adenovirus chromatin structure at different stages of infection. Mol Cell Biol 1: 1094-1105.
-
(1981)
Mol Cell Biol
, vol.1
, pp. 1094-1105
-
-
Daniell, E.1
Groff, D.E.2
Fedor, M.J.3
-
30
-
-
0018379829
-
Nucleosome-like structural subunits of intranuclear parental adenovirus type 2 DNA
-
Sergeant A, Tigges MA, Raskas HJ, (1979) Nucleosome-like structural subunits of intranuclear parental adenovirus type 2 DNA. J Virol 29: 888-898.
-
(1979)
J Virol
, vol.29
, pp. 888-898
-
-
Sergeant, A.1
Tigges, M.A.2
Raskas, H.J.3
-
31
-
-
0018389942
-
Parental adenovirus DNA accumulates in nucleosome-like structures in infected cells
-
Tate VE, Philipson L, (1979) Parental adenovirus DNA accumulates in nucleosome-like structures in infected cells. Nucleic Acids Res 6: 2769-2785.
-
(1979)
Nucleic Acids Res
, vol.6
, pp. 2769-2785
-
-
Tate, V.E.1
Philipson, L.2
-
32
-
-
0022746472
-
Adenoviral protein VII packages intracellular viral DNA throughout the early phase of infection
-
Chatterjee PK, Vayda ME, Flint SJ, (1986) Adenoviral protein VII packages intracellular viral DNA throughout the early phase of infection. EMBO J 5: 1633-1644.
-
(1986)
EMBO J
, vol.5
, pp. 1633-1644
-
-
Chatterjee, P.K.1
Vayda, M.E.2
Flint, S.J.3
-
33
-
-
79951858961
-
Cellular and viral chromatin proteins are positive factors in the regulation of adenovirus gene expression
-
Epub ahead of print
-
Komatsu T, Haruki H, Nagata K, (2010) Cellular and viral chromatin proteins are positive factors in the regulation of adenovirus gene expression. Nucleic Acids Res. Epub ahead of print.
-
(2010)
Nucleic Acids Res
-
-
Komatsu, T.1
Haruki, H.2
Nagata, K.3
-
34
-
-
33747773708
-
Histone H3 acetylation and H3 K4 methylation define distinct chromatin regions permissive for transgene expression
-
Yan C, Boyd DD, (2006) Histone H3 acetylation and H3 K4 methylation define distinct chromatin regions permissive for transgene expression. Mol Cell Biol 26: 6357-6371.
-
(2006)
Mol Cell Biol
, vol.26
, pp. 6357-6371
-
-
Yan, C.1
Boyd, D.D.2
-
35
-
-
40949135171
-
Strategic use of an adenoviral vector for rapid and efficient ex vivo-generation of cytomegalovirus pp65-reactive cytolytic and helper T cells
-
Forsberg O, Carlsson B, Totterman TH, Essand M, (2008) Strategic use of an adenoviral vector for rapid and efficient ex vivo-generation of cytomegalovirus pp65-reactive cytolytic and helper T cells. Br J Haematol 141: 188-199.
-
(2008)
Br J Haematol
, vol.141
, pp. 188-199
-
-
Forsberg, O.1
Carlsson, B.2
Totterman, T.H.3
Essand, M.4
-
37
-
-
77953701535
-
AdCD40L immunogene therapy for bladder carcinoma-the first phase I/IIa trial
-
Malmstrom PU, Loskog AS, Lindqvist CA, Mangsbo SM, Fransson M, et al. (2010) AdCD40L immunogene therapy for bladder carcinoma-the first phase I/IIa trial. Clin Cancer Res 16: 3279-3287.
-
(2010)
Clin Cancer Res
, vol.16
, pp. 3279-3287
-
-
Malmstrom, P.U.1
Loskog, A.S.2
Lindqvist, C.A.3
Mangsbo, S.M.4
Fransson, M.5
-
38
-
-
33646739571
-
Adenovirus-mediated CD40 ligand therapy induces tumor cell apoptosis and systemic immunity in the TRAMP-C2 mouse prostate cancer model
-
Dzojic H, Loskog A, Totterman TH, Essand M, (2006) Adenovirus-mediated CD40 ligand therapy induces tumor cell apoptosis and systemic immunity in the TRAMP-C2 mouse prostate cancer model. Prostate 66: 831-838.
-
(2006)
Prostate
, vol.66
, pp. 831-838
-
-
Dzojic, H.1
Loskog, A.2
Totterman, T.H.3
Essand, M.4
-
39
-
-
2442713854
-
Tissue-specific promoters for cancer gene therapy
-
Saukkonen K, Hemminki A, (2004) Tissue-specific promoters for cancer gene therapy. Expert Opin Biol Ther 4: 683-696.
-
(2004)
Expert Opin Biol Ther
, vol.4
, pp. 683-696
-
-
Saukkonen, K.1
Hemminki, A.2
-
40
-
-
27944471015
-
Development of transcriptionally regulated oncolytic adenoviruses
-
Ko D, Hawkins L, Yu DC, (2005) Development of transcriptionally regulated oncolytic adenoviruses. Oncogene 24: 7763-7774.
-
(2005)
Oncogene
, vol.24
, pp. 7763-7774
-
-
Ko, D.1
Hawkins, L.2
Yu, D.C.3
-
41
-
-
29144526658
-
An oncolytic conditionally replicating adenovirus for hormone-dependent and hormone-independent prostate cancer
-
Cheng WS, Dzojic H, Nilsson B, Totterman TH, Essand M, (2006) An oncolytic conditionally replicating adenovirus for hormone-dependent and hormone-independent prostate cancer. Cancer Gene Ther 13: 13-20.
-
(2006)
Cancer Gene Ther
, vol.13
, pp. 13-20
-
-
Cheng, W.S.1
Dzojic, H.2
Nilsson, B.3
Totterman, T.H.4
Essand, M.5
-
42
-
-
38449110249
-
Gene expression profiling induced by histone deacetylase inhibitor, FK228, in human esophageal squamous cancer cells
-
Hoshino I, Matsubara H, Akutsu Y, Nishimori T, Yoneyama Y, et al. (2007) Gene expression profiling induced by histone deacetylase inhibitor, FK228, in human esophageal squamous cancer cells. Oncol Rep 18: 585-592.
-
(2007)
Oncol Rep
, vol.18
, pp. 585-592
-
-
Hoshino, I.1
Matsubara, H.2
Akutsu, Y.3
Nishimori, T.4
Yoneyama, Y.5
-
43
-
-
48149089435
-
Characterisation of the in vitro activity of the depsipeptide histone deacetylase inhibitor spiruchostatin A
-
Crabb SJ, Howell M, Rogers H, Ishfaq M, Yurek-George A, et al. (2008) Characterisation of the in vitro activity of the depsipeptide histone deacetylase inhibitor spiruchostatin A. Biochem Pharmacol 76: 463-475.
-
(2008)
Biochem Pharmacol
, vol.76
, pp. 463-475
-
-
Crabb, S.J.1
Howell, M.2
Rogers, H.3
Ishfaq, M.4
Yurek-George, A.5
-
44
-
-
0033427145
-
Histone deacetylase inhibitor activates the p21/WAF1/Cip1 gene promoter through the Sp1 sites
-
Sowa Y, Orita T, Hiranabe-Minamikawa S, Nakano K, Mizuno T, et al. (1999) Histone deacetylase inhibitor activates the p21/WAF1/Cip1 gene promoter through the Sp1 sites. Ann N Y Acad Sci 886: 195-199.
-
(1999)
Ann N Y Acad Sci
, vol.886
, pp. 195-199
-
-
Sowa, Y.1
Orita, T.2
Hiranabe-Minamikawa, S.3
Nakano, K.4
Mizuno, T.5
-
45
-
-
33751248498
-
Valproic acid, a histone deacetylase inhibitor, is an antagonist for oncolytic adenoviral gene therapy
-
Hoti N, Chowdhury W, Hsieh JT, Sachs MD, Lupold SE, et al. (2006) Valproic acid, a histone deacetylase inhibitor, is an antagonist for oncolytic adenoviral gene therapy. Mol Ther 14: 768-778.
-
(2006)
Mol Ther
, vol.14
, pp. 768-778
-
-
Hoti, N.1
Chowdhury, W.2
Hsieh, J.T.3
Sachs, M.D.4
Lupold, S.E.5
|